Skip to content
Maxcyte Logo
  • Home
  • About Us
    • Leadership
    • Board of Directors
    • Company History
    • Careers
  • Life Sciences
    • Applications
      • Cell-Based Assays
      • Gene Editing
      • Primary Cells
      • Protein Production
      • Stem Cells
      • TCR/CAR T
    • Resources
      • Application Notes
      • Posters
      • Primary Literature
      • Product Literature
      • Webinar
      • White Papers
    • Instruments
      • ATx
      • GTx
      • STx
      • VLX
    • Consumables
      • RUO PAs
      • PA Accessories
      • GMP PAs
      • PA Order/Quote Request
    • Distributors
      • 2020 Webinars Series
      • Vaccine
  • CARMA™ Cell Therapies
  • Investors
    • Financial Information
      • Financial Reports
      • Calendar & Events
    • Corporate Materials
      • Presentations and Recordings
      • Shareholder Documents
      • Corporate Deck
    • Stock Information
      • IR Email Alerts
      • Analyst Coverage
      • Press Releases
    • Corporate Governance
      • QCA Adoption
      • Senior Management
      • Board of Directors
  • News/Events
    • Press Releases
    • Upcoming Events
    • Virtual 3D booth
    • Media Contact
    • MaxCyte® Minutes
  • Contact Us

Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma

Home/Resources/Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma

Previous Next

Engineering NK Cells with High-Affinity CD16 for Enhanced Combination Therapy to Treat B-Cell Lymphoma

ali2020-05-05T16:20:19+00:00May 5th, 2020|Resources|0 Comments

Share This Story, Choose Your Platform!

FacebookTwitterLinkedInRedditWhatsAppTumblrPinterestVkEmail

Leave A Comment Cancel reply

MaxCyte, Inc.

22 Firstfield Road, Suite 110
Gaithersburg, MD 20878
Tel: +1-301-944-1700
Fax: +1-301-944-1703

Life Sciences

CARMA™ Cell Therapies

Careers

Applications

Investors

Expert Platform

Instruments

About Us

Resources

Contact Ustwitter linkedin
MaxCyte®, ExPERT®, CARMA® MaxCyte STx®, MaxCyte ATx®, MaxCyte GTx®, MaxCyte VLX®, Flow Transfection®, Flow Electroporation®, Any Cell. Any Molecule. Any Scale®, GTx®, ATx®, and STx® logos are trademarks of MaxCyte, Inc. registered in the U.S. Patent and Trademark Office. ExPERT ATx™, ExPERT GTx™, and ExPERT STx™ are trademarks of MaxCyte, Inc.

By visiting the MaxCyte.com website, you accept that we use cookies. You are anonymous as a user of the MaxCyte.com website. We do not register any information that can identify you personally. Read more about our use of cookies. Find out more.
Go to Top